Analyst Ratings for Cardiome Pharma (CRME)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2011 | BMO Capital | N/A | New Coverage | Outperform (N/A) |
11.00 (N/A) |
3.57 (2.13) |
-40.34% | Details |
| 7/26/2011 | Canaccord Genuity | N/A | Upgrade | Buy (N/A) |
8.00 (N/A) |
4.86 (2.13) |
-56.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
